Access cutting-edge partial-onset epilepsy treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Hartford location
Access partial-onset epilepsy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related partial-onset epilepsy treatment provided free
Check if you qualify for this partial-onset epilepsy clinical trial in Hartford, CT
No-Cost Study Care
Local to Hartford
Convenient for CT residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Cenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal) seizures in adult subjects (≥18 years of age). In the US it is approved for use as monotherapy, however, there is little clinical data assessing its use as monotherapy in adults with POS. This study is designed to explore the effectiveness of doses of 100 mg/day and 200 mg/day as monotherapy in adult subjects with newly diagno
Sponsor: SK Life Science, Inc.
Yes, this clinical trial (NCT06453213) has an active research site in Hartford, CT that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for partial-onset epilepsy treatment options in Hartford, CT, this clinical trial (NCT06453213) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced partial-onset epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all partial-onset epilepsy clinical trials near you to find additional studies recruiting in your area.
See all epilepsy clinical trials recruiting in Hartford — not just this study.
Browse Epilepsy Trials in Hartford →